20142023年浙江省杭州市萧山区户籍女性乳腺癌发病和死亡趋势

The incidence and mortality trend of breast cancer among women with registered residence in Xiaoshan District of Hangzhou City in Zhejiang Province from 2014 to 2023

  • 摘要:
    目的 分析2014—2023年浙江省杭州市萧山区户籍女性乳腺癌发病率、死亡率变化趋势及乳腺癌患者生存率,为完善乳腺癌防控策略提供依据。
    方法 通过浙江省慢性病监测管理系统收集2014—2023年萧山区户籍女性乳腺癌发病和死亡数据,计算乳腺癌粗发病率、粗死亡率及中国人口标化率(简称“中标率”)和世界人口标化率(简称“世标率”)。采用Joinpoint模型分析发病率、死亡率的变化趋势;采用R 4.1.1软件分析5年相对生存率评估乳腺癌患者生存情况。
    结果 2014—2023年,萧山区户籍女性乳腺癌粗发病率为70.00/10万~128.35/10万,中标发病率和世标发病率分别为52.92/10万~94.29/10万和40.82/10万~72.07/10万,平均年度变化百分比(AAPC)分别为5.80%、4.63%和4.71%,10年间呈增长趋势(均P<0.05)。2014—2023年30~<40岁、50~<75岁年龄段人群乳腺癌发病率呈增长趋势(均P<0.05)。女性乳腺癌死亡粗率为7.75/10万~12.34/10万,中标死亡率为4.62/10万~7.53/10万,世标死亡率为3.58/10万~5.71/10万,AAPC无统计学意义(P>0.05);但死亡率随年龄增长而增高(P<0.001)。2016—2018年萧山区女性乳腺癌5年年龄标化相对生存率为94.46%,高于2013—2015年的91.02%(P<0.05)。
    结论 2014—2023年浙江省杭州市萧山区户籍女性乳腺癌年度发病率呈增长趋势,死亡率变化趋势不明显。女性乳腺癌5年生存率较高,综合防控成效明显。应继续加强乳腺癌防控宣传,控制乳腺癌高危因素,积极开展目标人群乳腺癌早诊早治,提高乳腺癌患者生存质量。

     

    Abstract:
    Objective To analyze the trend of incidence, mortality rate and survival rate of breast cancer among women with registered residence in Xiaoshan District of Hangzhou City in Zhejiang Province from 2014 to 2023, and to provide a basis for improving breast cancer prevention and control strategies.
    Methods Data on the incidence and mortality of breast cancer among women with registered residence in Xiaoshan District from 2014 to 2023 were collected through Zhejiang Chronic Disease Monitoring and Management System. The crude incidence and mortality rate, as well as the age-standardized incidence and mortality rate using both the 2000 Chinese standard population (abbreviated as “Chinese ASR”) and Segi’s 1960 world standard population (“world ASR”) were calculated. Joinpoint model was employed to analyze the trends in incidence and mortality rate, while R software (version 4.1.1) was used to analyze the 5-year relative survival rate to assess the survival status of breast cancer patients.
    Results From 2014 to 2023, the crude incidence rate, the Chinese age-standardized incidence rate (ASIRC) and the world age-standardized incidence rate (ASIRW) of breast cancer among women with registered residence in Xiaoshan District were from 70.00/100 000 to 128.35/100 000, from 52.92/100 000 to 94.29/100 000, and from 40.82/100 000 to 72.07/100 000, respectively, with the corresponding average annual percentage changes (AAPC) of 5.80%, 4.63% and 4.71%, respectively, showing a significant increasing trend over the decade (all P<0.05). The incidence rate of breast cancer among people aged 30‒<40 years old or 50‒<75 years old exhibited a significant increase trend from 2014 to 2023 (all P<0.05). The crude mortality rate of breast cancer in female was from 7.75/100 000 to 12.34/100 000, the ASMRC of breast cancer in female was from 4.62/100 000 to 7.53/100 000, and the ASMRW of breast cancer in female was from 3.58/100 000 to 5.71/100 000, and the AAPC had no statistically significance. However, the mortality rate of breast cancer was increased with age (P<0.001). The 5-year age-standardized relative survival rate of breast cancer in female in Xiaoshan District was significantly higher in the 2016‒2018 period (94.46%) compared to the 2013‒2015 period (91.02%) (P<0.05).
    Conclusion From 2014 to 2023, the annual incidence of breast cancer among women with registered residence in Xiaoshan District of Hangzhou City in Zhejiang Province showed an increasing trend, while the change in mortality rate was not statistically significant. The 5-year survival rate of breast cancer in female was at a high level, indicating notable achievements in comprehensive prevention and control efforts. It is essential to continue to strengthen public awareness campaigns for breast cancer prevention and control, control breast cancer risk factors, actively carry out early diagnosis and treatment of breast cancer among target groups, and improve the quality of life for breast cancer patients.

     

/

返回文章
返回